{
    "article_id": "FIN-002",
    "headline": "Small biotech CureGen soars on FDA approval, analysts remain skeptical",
    "content": "CureGen (NASDAQ: CURE), a small-cap biotech, received FDA approval for its novel c",
    "published_at": "2024-11-01T14:30:00Z"
}
